Yposkesi

Paris, France Founded: 2016 • Age: 10 yrs Acquired By SK
Gene and cell therapy products, including lentiviral vectors, are manufactured.
Request Access

About Yposkesi

Yposkesi is a company based in Paris (France) founded in 2016 was acquired by SK in March 2021.. Yposkesi offers products and services including Process Development, Viral Vector Manufacturing, Plasmid DNA Manufacturing, and Cell Therapy Manufacturing.

  • Headquarter Paris, France
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Sk Pharmteco Inc.
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    SK

    (Mar 31, 2021)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Yposkesi

Yposkesi offers a comprehensive portfolio of products and services, including Process Development, Viral Vector Manufacturing, Plasmid DNA Manufacturing, and Cell Therapy Manufacturing. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Efficient development for cell and gene therapy processes.

Scalable production of viral vectors for gene therapies.

Production of plasmid DNA for therapy development.

CGMP manufacturing for autologous and allogeneic therapies.

Funding Insights of Yposkesi

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Yposkesi

Yposkesi has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include SK. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Private equity firm focused on energy, chemical, semiconductor, logistics, and multiple sectors
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Yposkesi

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Yposkesi

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Yposkesi Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Yposkesi

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Yposkesi

Frequently Asked Questions about Yposkesi

When was Yposkesi founded?

Yposkesi was founded in 2016.

Where is Yposkesi located?

Yposkesi is headquartered in Paris, France.

Who is the current CEO of Yposkesi?

Alain Lamproye is the current CEO of Yposkesi.

What does Yposkesi do?

Yposkesi was founded in 2016 in Paris, France, as a biotechnology firm focused on gene and cell therapy. Lentiviral and adenoviral vectors, along with CD34 cells for ex vivo applications, are produced. Contract manufacturing services are also provided to support related therapeutic developments in the sector. Operations emphasize advanced vector technologies for clinical and research needs.

What products or services does Yposkesi offer?

Yposkesi offers Process Development, Viral Vector Manufacturing, Plasmid DNA Manufacturing, and Cell Therapy Manufacturing.

Who are Yposkesi's investors?

Yposkesi has 1 investor. Key investors include SK.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available